Cormorant Asset Management LLC is a hedge fund management firm based in Boston, Massachusetts, United States. It manages pooled investment vehicles and invests in venture capital. In this article, we’ll explore how the firm invests in venture capital and makes a profit by not paying its employees. But why would it do this? What makes it special? And how does it work? Here are some reasons why:
Bihua Chen founded Cormorant Asset Management LLC
Bihua Chen is the founder of Cormorant Asset Management LLC. The firm specializes in medical and biotechnology companies. Bihua has managed a public and private fund and previously served as a sub-adviser at a large multi-strategy hedge fund. Bihua Chen has a bachelor’s degree in genetics and genetic engineering and an MBA from the Wharton School.
The firm was founded by Bihua Chen, a former banker who currently manages funds for investors. Chen’s educational background includes finance, marketing, and operations. She has been an entrepreneur and has held management positions in various companies including organic food and natural grocery chains. Chen has also worked at companies that produce and market fresh fruits and vegetables. One of her current investments is Organic Alliance, Inc., which markets organic fruits and vegetables to supermarkets, natural grocery chains, and mass merchandisers. She has experience in marketing, sales, and service for organic produce.
It invests in venture capital
Cormorant Asset Management is an investment vehicle, hedge fund, and venture capital firm. Based in Boston, Massachusetts, this firm specializes in finance and asset management. Its portfolio companies include more than 75 ventures that have gone on to successful exits. The firm has a child hub called Cormorant Asset Management Portfolio Companies. Its portfolio companies are primarily focused on companies in the areas of accounting, engineering, measurement, and controlling.
The company’s portfolio contains 77 stocks, with an estimated $1.2 billion USD under management. Its top holdings are Turning Point Therapeutics Inc. (US:TPTX), Erasca, Inc. (US:ERAS), and Greenlight Biosciences Holdings PBC A (US:39536G1058). The company also has several new positions. It has a 3% loss rate, and the firm has a history of making profits.
It manages pooled investment vehicles
The firm’s primary business is the management of pooled investment vehicles. The firm advises clients in public equity markets and uses fundamental analysis to build investment portfolios. Unlike many other fund managers, Cormorant only invests in pools of money, not individual accounts. Its Massachusetts headquarters is located at 200 Clarendon Street, and it does not have any offices outside the country. Its clients include individuals, corporations, and other investment firms, but most of them are non-related to Cormorant Asset Management.
Some pooled investment vehicles have a lower risk than individual investments, and they may be more liquid. Other pooled investments have higher volatility and liquidity than individual investments, so it’s important to research each fund thoroughly before purchasing. Investors should consider the fees and risk rate before investing in any pooled investment vehicle. In addition to fees, investors should consider the type of underlying holdings.
